RBI rejects merger of Indiabulls Housing Finance with Lakshmi Vilas Bank RBI rejects merger of Indiabulls Housing Finance with Lakshmi Vilas Bank DSIJ Intelligence / Thursday, October 10, 2019 / Article rating: 5.0 The news is likely to have an adverse impact on the stocks of both the private sector bank and the mortgage financier.
Domestic MF AUM declines by 4 per cent. Domestic MF AUM declines by 4 per cent. DSIJ Intelligence / Wednesday, October 9, 2019 / Article rating: 5.0 The latest data by industry body, Association of Mutual Funds in India (AMFI) shows that asset under management (AUM) of the domestic mutual fund has declined by 3.8% month on month basis.
Polycab India opens its second Experience Centre Polycab India opens its second Experience Centre DSIJ Intelligence / Wednesday, October 9, 2019 / Article rating: 3.5 Polycab India Limited on Wednesday announced that the company has inaugurated Polycab Experience Centre at Shop No. 1, Sakharam Apartment, old Tapkir Galli, Pune.
Religare Enterprises to conduct postal ballot for disinvestment Religare Enterprises to conduct postal ballot for disinvestment DSIJ Intelligence / Wednesday, October 9, 2019 / Article rating: 5.0 Last week, Religare Enterprises announced that the company will conduct postal ballot to obtain approval of the shareholders of the company by the way of special resolution on disinvestment of entire investment of the company in material subsidiaries and Religare Housing Development Finance Corporation Limited and Sales, disposal and leasing of assets exceeding 20 per cent of assets of Religare Finvest Limited.
Understanding the game of needs and wants Understanding the game of needs and wants DSIJ Intelligence / Wednesday, October 9, 2019 / Article rating: 5.0 Usually, people use the words “need” and “want” interchangeably. However, they are way different from each other. Read on to find out more.
Zydus Cadila gets USFDA approval for Colesevelam Hydrochloride Tablets Zydus Cadila gets USFDA approval for Colesevelam Hydrochloride Tablets Apurva Joshi / Wednesday, October 9, 2019 / Article rating: 5.0 Zydus Cadila has received the final approval from the United States Federation of Drug Authority (USFDA) to market Colesevelam Hydrochloride Tablets, (US RLD - Welchol), 625 mg. It will be manufactured at the group’s formulations manufacturing facility at SEZ, Ahmedabad.
Ten stocks close to their 52-weeks low Ten stocks close to their 52-weeks low DSIJ Intelligence / Wednesday, October 9, 2019 / Article rating: 4.2 Following stocks are close to their 52-weeks low as at 14:15 p.m. on October 09, 2019.
Ten stocks close to their 52-weeks high Ten stocks close to their 52-weeks high DSIJ Intelligence / Wednesday, October 9, 2019 / Article rating: 5.0 The markets on October 09, 2019 opened gap up. BSE Sensex is trading at 37,991.57, up by 459.59 points and the Nifty is closed at 11,256.80, up by 130.40 points.
Lupin gets GMP certificate for Mandideep API facility Lupin gets GMP certificate for Mandideep API facility Apurva Joshi / Wednesday, October 9, 2019 / Article rating: 4.5 Lupin Limited has informed the bourses that it has received GMP (Good Manufacturing Practice) Certificate from the Pharmaceutical and Medical Devices Agency (PMDA), Japan for its Mandideep API facility (Unit II).
BHEL gains on new order win BHEL gains on new order win Nidhi Jani / Wednesday, October 9, 2019 / Article rating: 4.0 The public sector company informed the exchanges that it has won orders for the Turbine Generator and associated packages for the greenfield 2x660 MW Khurja Super Thermal Power Project situated at Bulandshahr district of Uttar Pradesh.